ChristianaCare

ChristianaCare

Hospitals and Health Care

Newark, Delaware 49,341 followers

For the Love of Health

About us

Headquartered in Wilmington, Delaware, ChristianaCare is one of the country’s most dynamic health care organizations, centered on improving health outcomes, making high-quality care more accessible and lowering health care costs. ChristianaCare includes an extensive network of primary care and outpatient services, home health care, urgent care centers, three hospitals (1,336 beds), a freestanding emergency department, a Level I trauma center and a Level III neonatal intensive care unit, a comprehensive stroke center and regional centers of excellence in heart and vascular care, cancer care and women’s health. It also includes the pioneering Gene Editing Institute. ChristianaCare is nationally recognized as a great place to work, rated by Forbes as the 2nd best health system for diversity and inclusion, and the 29th best health system to work for in the United States, and by IDG Computerworld as one of the nation’s Best Places to Work in IT. ChristianaCare is rated by Healthgrades as one of America’s 50 Best Hospitals and continually ranked among the nation’s best by U.S. News & World Report, Newsweek and other national quality ratings. ChristianaCare is a nonprofit teaching health system with more than 260 residents and fellows. With its groundbreaking Center for Virtual Health and a focus on population health and value-based care, ChristianaCare is shaping the future of health care.

Industry
Hospitals and Health Care
Company size
10,001+ employees
Headquarters
Newark, Delaware
Type
Nonprofit
Specialties
Large Health System, Level 1 Trauma, Level III Neonatal ICU, Magnet®, Major Teaching Hospital, Home Health, Cancer Center, Heart & Vascular Health, Cancer Research, Virtual Ed & Simulation Training, Memory Care, Advanced Joint Replacement, and Surgical Centers

Locations

Employees at ChristianaCare

Updates

Affiliated pages

Similar pages

Browse jobs

Funding

ChristianaCare 3 total rounds

Last Round

Grant

US$ 2.5M

See more info on crunchbase